Special Issue "Biological Biomarkers of Mild Traumatic Brain Injury"
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 99
Interests: receptor of advanced glycation endproducts; retinoids; acute respiratory distress syndrome; premature rupture of membranes; sterile inflammation; diseases biomarkers; traumatic brain injury; S100B protein
Special Issues, Collections and Topics in MDPI journals
Of the three types of TBI (mild, moderate and severe), mild traumatic brain injury (TBI) is the most frequent (80%). Despite its name, mild TBI can result in death and intracranial lesions for 5 to 10% of the affected patients. The diagnosis of such complications was based on clinical examination, the identification of risk factors and imagery (the gold standard is CT scan tomography). Due to its low relative ability to identify intracranial lesions, the use of CT scan is limited, and due to excessive radiation potentially leading to cancer, repeated CT scanning is not recommended. In recent years, alternative diagnosis tools have been identified and the biological markers have been highly tested and developed. This Special Issue welcomes original papers and reviews dealing with the implications of biological biomarkers in the diagnosis and prognosis of the mild traumatic brain injury.
Prof. Dr. Vincent Sapin
Prof. Dr. Damien Bouvier
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- mild traumatic brain injury
- blood biomarker
- salivary biomarkers